evipedia.aidev
← Back

Mung Bean Extract for Health & Longevity

Evidence Review created on 08/15/2026 using AI4L / Grok 4

Also known as: Vigna radiata extract, green gram extract, mungbean extract, mung bean seed coat extract, mung bean protein isolate

Motivation

Mung bean extract is a concentrated preparation from the mung bean, an Asian staple bean also sold as green gram. Commercial forms include seed-coat extracts rich in two plant flavones, and protein isolates built around the seed’s main storage protein. People who optimize health and lifespan meet the extract as a traditional cooling food, an inflammation-support capsule, or a compact plant protein with metabolic claims.

Cooks across China and South Asia have long used mung bean soup as a summer heat food. Laboratories later found that the seed coat holds most of the flavones, that those flavones can appear in animal blood after oral dosing, and that the main storage protein resembles a soy protein already studied for blood fats. A handful of human protein-isolate studies now sit beside a much larger animal and cell literature.

This review examines what the extract is, the evidence for metabolic and inflammatory outcomes and for lifespan-related claims, and the allergy, gut, and product-quality issues that decide whether a concentrated form differs from eating the bean.

Benefits - Risks - Protocol - Conclusion

High-level overviews that name mung bean extract, its coat flavones, or the protein isolate and place those preparations in a health context.

No dedicated mung bean extract discussion was found from Rhonda Patrick, Peter Attia, Andrew Huberman, Chris Kresser, or Lifespan.io. Life Extension is the only prioritized platform with a substantial, on-topic feature.

Grokipedia

No Grokipedia article for mung bean extract was found.

Examine

No Examine.com article for mung bean extract was found.

ConsumerLab

No ConsumerLab article for mung bean extract was found.

Systematic Reviews

No systematic reviews or meta-analyses for Mung Bean Extract were found on PubMed as of August 15, 2026. Claimed metabolic effects and the principal allergy risk are both unrepresented.

Mechanism of Action

Mung bean extract is a mixture, not a single drug. Seed-coat products concentrate the C-glycosyl flavones vitexin (apigenin-8-C-glucoside) and isovitexin (apigenin-6-C-glucoside), which account for most coat phenolics. These quench reactive oxygen species, inhibit starch- and fat-digesting enzymes in the test tube, and in immune cells reduce release of HMGB1 while turning on autophagy (the cell’s debris-clearing program). Coat extract also activates AMP-activated protein kinase (AMPK, a fuel-sensing enzyme) in worm and cell models of Alzheimer- and Parkinson-type protein clumps.

Protein isolates are dominated by 8S globulin, structurally close to soy β-conglycinin. Digestion releases peptides that inhibit angiotensin-converting enzyme (ACE, which tightens vessels and raises blood pressure) in vitro. In humans, the isolate has lowered insulin-resistance scores and triglycerides, possibly by damping sterol regulatory element-binding protein 1 (SREBP-1, a fat-making switch) and shifting gut microbes.

Vitexin is poorly absorbed as a C-glycoside. Gut microbes transform it; rodent work shows plasma appearance after oral coat extract, with a short residence time and little intact compound in tissues. Human oral bioavailability is low. Protein isolate is handled as food protein over several hours, not as a receptor-selective drug. Fuji Oil, which sells the isolate used in the metabolic trials, and Life Extension, which sells a coat-extract capsule, each have a commercial interest in these mechanisms.

Historical Context & Evolution

Vigna radiata was domesticated on the Indian subcontinent by about 1500 BCE and spread through East and Southeast Asia as food and medicine. Chinese sources from the eleventh century treat mung bean as a cooling food for summer heat and selected inflammatory states. That folk use is the direct ancestor of today’s seed-coat extracts: later chemistry showed that vitexin and isovitexin sit almost entirely in the coat, and that both appear in rat plasma after oral dosing and blunt heat-stress oxidation.

A second modern thread is protein. In 2006, Li and colleagues isolated ACE-inhibitory peptides from alcalase hydrolysates of mung bean protein. Fuji Oil then commercialized an 8S-globulin isolate (GLUCODIA) on the claim that it mimics soy β-conglycinin at a lower gram dose. Industry-funded human trials followed in North America.

A third thread is late inflammation. In 2012, Zhu, Wang, and colleagues at the Feinstein Institute reported that oral coat extract raised survival in septic mice by driving autophagic disposal of HMGB1. Life Extension built a coat-extract plus green-tea capsule on that paper. In 2021, Tao and colleagues reported that coat flavonoids extended Caenorhabditis elegans lifespan. None of these lines has produced an independent, large human outcomes trial. Traditional soup, coat extract, and protein isolate remain distinct products that are often marketed as if they were interchangeable.

Expected Benefits

Medium 🟩 🟩

Insulin Sensitivity

Isolated mung bean protein (3 g/day of an 8S-globulin isolate) lowered fasting insulin and HOMA-IR (homeostatic model assessment of insulin resistance, a calculated resistance score) over 8 weeks in two Fuji Oil–sponsored double-blind trials, without lowering fasting glucose. The protein resembles soy β-conglycinin and may suppress hepatic fat-making genes. The failed glucose endpoint and manufacturer funding keep certainty below high.

Magnitude: In the main 3 g/day isolate trial, fasting insulin fell from 14.9 to 10.8 μU/mL and HOMA-IR from 3.8 to 2.9 over 8 weeks; fasting plasma glucose did not (102 to 99 mg/dL). Dose-finding 3 g and 6 g arms moved glucose versus control, but the main trial did not repeat a glucose drop (Kohno et al., 2018).

Fasting Triglycerides

The same isolate program lowered mean triglycerides versus placebo, including a fall from an elevated baseline to under 100 mg/dL (1.13 mmol/L) by week 4 at 3 g/day in the dose-finding cohort. Parallel mouse work from the same manufacturer showed less diet-induced liver fat. Independent replication has not been published.

Magnitude: Triglycerides declined versus placebo over 8 weeks at 3 g/day isolate; the dose-finding 3 g arm moved an elevated baseline to under 100 mg/dL by week 4 (Kohno et al., 2018; Watanabe et al., 2017).

Low 🟩

Endothelial Function

A six-week randomized drink trial in adults aged 45–60 found that 10 g or 15 g/day mung bean protein raised flow-mediated dilation (FMD, ultrasound widening of the brachial artery after cuff release). Soy powder was in both drinks; the contrast was added protein concentrate.

Magnitude: FMD percent-change rose at both 10 g and 15 g versus placebo after 6 weeks; the paper reports the direction and significance, not a single millimeter or percentage-point effect size (Muchimapura et al., 2024).

Strength in Underactive Vegetarians

In sedentary vegetarians, 18 g/day mung bean protein for 8 weeks did not change lean mass versus control, but combined grip and knee-strength change favored protein. That is a small add-on in a low-activity group, not a hypertrophy finding.

Magnitude: Combined strength change was +2.9% with protein versus −2.6% in controls (p = 0.05, the usual cutoff for a result unlikely to be chance); lean mass did not differ (Bartholomae et al., 2019).

Heat-Stress Oxidative Injury

Coat flavones (more than 96% of seed vitexin/isovitexin) appear in rat plasma after oral extract and lower heat-induced lipid peroxidation and enzyme leak. That chemistry matches the traditional summer-soup use. No controlled human heat-illness trial of a standardized extract exists.

Magnitude: Not quantified in available studies. No controlled human trial has measured heat-illness or exertional-heat outcomes; the figures are from heat-stressed rats given coat extract (Cao et al., 2011).

Late Inflammatory Signaling

Oral coat extract raised survival in a mouse sepsis model by clearing HMGB1. A later human protein-drink trial lowered nuclear factor kappa B (NF-κB, a master inflammatory switch) and related cytokines. The human data are mediator changes, not infection outcomes.

Magnitude: Mouse survival rose from 29.4% to 70% with oral coat extract (n = 17 per group). Human trials report lower inflammatory mediators without a standardized clinical effect size (Zhu et al., 2012; Muchimapura et al., 2024).

Hepatic Fat Handling

Manufacturer mouse work found less liver-fat buildup (steatosis), fibrosis, and inflammation on a fatty-liver diet when protein replaced other protein. The human isolate trials reported a move in liver enzymes within the reference range. This is a metabolic-adjacent signal, not a biopsy-proven human fatty-liver treatment.

Magnitude: Human liver enzymes improved within the normal band over 8 weeks of isolate; the steatosis, fibrosis, and inflammation reductions are mouse histologic findings without a human imaging or biopsy figure (Watanabe et al., 2017; Kohno et al., 2018).

Speculative 🟨

Lifespan Extension

Coat extract extended life and stress resistance in C. elegans and engaged mitochondrial, calorie-restriction-like, and histone-modifying paths. No mammal lifespan study, let alone a human one, exists. The basis is worm phenomenology plus flavone chemistry.

Neuroprotection in Protein-Aggregation Models

Coat extract reduced amyloid, tau, and α-synuclein burden in worms and cells via AMPK-dependent autophagy; vitexin and isovitexin were the active peaks. Human cognitive or motor outcomes have not been measured.

Anticancer Activity in Models

Extracts and flavones show antiproliferative and pro-apoptotic activity in cell lines; bean-as-food epidemiology is sometimes cited in support. No extract trial in people with cancer exists, and food-frequency findings do not transfer to capsules.

Blood-Pressure Lowering via ACE-Active Peptides

Alcalase peptides inhibit ACE in the test tube, and rat hydrolysate or sprout extracts have lowered systolic pressure. Human isolate trials found no blood-pressure change. The basis is mechanistic and animal only.

Benefit-Modifying Factors

  • Genetic variation: No extract-specific pharmacogene is established. Birch-pollen IgE (the antibody class that drives immediate allergy) to Bet v 1 predicts sprout and seed cross-reaction and can make the product unusable (Guhsl et al., 2014).

  • Baseline insulin resistance: Isolate effects on HOMA-IR and triglycerides were larger when baseline HOMA-IR was already above about 1.7; insulin-sensitive users have less room to move (Kohno et al., 2018).

  • Sex: Published isolate and drink trials enrolled both sexes and did not report a robust sex-split efficacy difference. Allergen work includes both sexes; no extract dose adjustment by sex is defined.

  • Pre-existing metabolic disease: Impaired fasting glucose, high triglycerides, and fatty-liver chemistry were the settings in which isolate signals appeared. Frank diabetes on drug therapy was generally excluded.

  • Age: Endothelial data are from ages 45–60. Isolate trials skewed younger-to-middle adult. Older adults have more allergy and polypharmacy risk and no dedicated efficacy trial.

Potential Risks & Side Effects

Medium 🟥 🟥

IgE-Mediated Allergy, Including Pollen-Food Cross-Reaction

Mung bean seed proteins include cupin storage globulins and albumins (Vig r 2–5) that bind IgE and resist pepsin. Sprouts also carry Vig r 1 and Vig r 6, which cross-react with birch Bet v 1. Case reports describe oral swelling after sprouts in birch-allergic people. Protein isolates concentrate storage globulins; coat extracts carry less protein but are not allergen-free unless tested. Fuji Oil has stated that isolate allergy is unreported compared with soy; that claim sits next to a documented allergen file, not in place of it.

Magnitude: Of 60 birch-allergic sera, 73% bound Vig r 1 and 32% bound Vig r 6; among 19 people with sprout reactions or positive prick tests, binding was 79% and 63% (Guhsl et al., 2014; Misra et al., 2011; Kobayashi et al., 2023).

Low 🟥

Gastrointestinal Fermentation Symptoms

Whole mung beans carry raffinose-family oligosaccharides (hard-to-digest sugars) and fiber that commonly cause gas and bloating. Low-fiber coat extracts and washed protein isolates contain far less of that load. Isolate and drink trials reported good tolerance, without a published numeric rate for bloating.

Magnitude: Gas and bloating rise with whole-bean portions; standardized coat-extract and isolate trials have not published a numeric gastrointestinal adverse-event rate (Dahiya et al., 2015; Kohno et al., 2018).

Mineral Binding by Phytate

Raw seed is rich in phytic acid, which can cut absorption of iron, zinc, and calcium from the same meal. Processing, soaking, and isolation lower phytate. This matters more for frequent whole-bean meals than for a few hundred milligrams of coat extract.

Magnitude: Phytate can cut mineral absorption from a high-phytate bean meal by as much as about half; coat-extract capsules have not been shown to reproduce that meal-level effect (Dahiya et al., 2015).

Speculative 🟨

Additive Blood-Pressure Lowering with ACE-Active Drugs

Alcalase peptides inhibit ACE in the test tube. No human isolate trial has shown an important blood-pressure drop, so combined use with ACE inhibitors (blood-pressure drugs) is a mechanistic caution only.

Contaminants in Unverified Botanicals

Like other plant extracts, untested lots can carry heavy metals, residual solvent, or misidentified legumes. This is a quality failure mode, not a specific toxicology finding for authentic V. radiata extract.

Risk-Modifying Factors

  • Genetic / atopic status: Birch, soy, peanut, or other legume sensitization raises the chance that seed or sprout proteins will trigger IgE symptoms (Guhsl et al., 2014).

  • Baseline inflammatory load: People with high HMGB1-pathway drive were the conceptual target of coat extract; they are also more likely to be on drugs that interact with blood pressure or glucose.

  • Sex: No consistent sex difference in extract adverse events is published. Pregnancy and lactation lack concentrated-extract safety data.

  • Pre-existing allergy or asthma: Prior oral-allergy syndrome (mouth and throat itch after raw plant foods), sprout reactions, or unstable asthma raise the cost of a first isolate or sprout-derived product.

  • Age: Older adults have more ACE-inhibitor and glucose-drug use and a higher pretest probability of pollen-food syndrome; isolate trials did not enroll the old-old.

Key Interactions & Contraindications

  • ACE inhibitors and angiotensin-receptor blockers (lisinopril, ramipril, losartan): Caution. Hydrolysate peptides inhibit ACE in vitro; combined hypotension (low blood pressure) is unproven but plausible. Monitor blood pressure after starting (Li et al., 2006).

  • Glucose-lowering drugs (metformin, SGLT2 (sodium-glucose cotransporter 2) inhibitors (drugs that increase urinary glucose excretion) such as empagliflozin, and insulin): Caution. Isolate can lower insulin-resistance scores; additive low blood sugar is undocumented but worth glucose checks in the first weeks (Kohno et al., 2018).

  • Other antihypertensives (amlodipine, hydrochlorothiazide): Caution. Any ACE-like peptide effect is additive in principle. Monitor sitting and standing blood pressure.

  • Iron or zinc supplements: Monitor. Whole-bean phytate can blunt same-meal mineral uptake; separate mineral doses from large bean meals. Coat-extract capsules are a smaller concern (Dahiya et al., 2015).

  • Green-tea catechins (EGCG, epigallocatechin gallate): Caution. Often combined with coat extract in commercial capsules. Additive antioxidant and nausea risk; this is a common marketed combination, not a proven synergy in humans.

  • Other polyphenol-rich extracts (grape seed, cocoa flavanols): Caution. Additive gastric upset is the main practical issue; no unique pharmacokinetic clash is defined.

  • Over-the-counter medications (ibuprofen, naproxen, calcium carbonate, loratadine): No specific interaction with coat extract or isolate is documented. Monitor only if combined with ACE-active or mineral-binding products.

Populations who should avoid Mung Bean Extract:

  • Documented IgE allergy to mung bean, green gram, or mung sprouts
  • Birch-pollen food syndrome with prior sprout or raw-legume oral symptoms, unless an allergist has cleared the specific product
  • Anaphylaxis (a sudden, whole-body allergic reaction) to peanut, soy, or other legumes until cross-reactivity is assessed
  • Concentrated extract use in pregnancy or lactation (no adequate product-level data)
  • Infants and young children, for whom extract products are unstudied

Risk Mitigation Strategies

  • Allergen screen before first isolate: People with birch, soy, or peanut allergy start with a medically supervised exposure plan, which prevents IgE reactions that a coat-flavone capsule will not treat.

  • Form-matched product: Choose coat extract for flavone aims and isolate for protein aims, which avoids a high intake of the wrong fraction and the associated gut or allergy load.

  • Low first-week dose: Begin isolate at 3 g/day or coat extract at a single commercial serving, which limits first-exposure allergic and gastric events.

  • Glucose and pressure logs with combined use: Users on ACE inhibitors or glucose drugs record home readings for 2 weeks, which catches additive hypotension or unexpected glucose change.

  • Third-party tested lots: Independent seals such as USP or NSF reduce heavy-metal and identity failures that untested botanicals carry.

  • Separate minerals from large bean meals: Move iron or zinc at least 2 hours from whole-bean portions, which limits phytate binding; small coat-extract capsules need less separation.

Therapeutic Protocol

  • Competing forms: Practitioners split into a Feinstein/Life Extension coat-extract inflammation protocol, a Fuji Oil isolate metabolic protocol, and a traditional soup-as-food pattern. None is the default.

  • Coat-extract dose: Commercial inflammation-support capsules often deliver about 240 mg seed-coat extract, commonly paired with a green-tea catechin. That serving is a marketing standard, not an outcomes-tested human dose.

  • Protein-isolate dose: Metabolic trials used 3 g/day isolate as the lowest active amount; drink and strength studies used 10–18 g/day protein. Higher grams track protein nutrition more than flavone pharmacology.

  • Time of day: Metabolic isolate trials used chewable tablets twice daily before breakfast and dinner. Coat extract is usually taken with food to limit gastric upset. No circadian advantage is established.

  • Half-life: Intact vitexin is short-lived in rodent plasma and poorly bioavailable orally; human isolate is digested over several hours like other food proteins. Twice-daily split is optional, not required.

  • Single versus split dose: The 3 g isolate dose was split twice daily in the Kohno metabolic trials. Large protein servings (10–18 g) are often split if they displace a meal.

  • Genetics: No dose rule exists for MTHFR (folate-processing gene), COMT (dopamine-clearing gene), or CYP (drug-metabolizing enzymes). Birch-related sensitization is the factor that changes product choice.

  • Sex: No sex-specific extract dose is defined. The same gram amounts were used in mixed-sex trials.

  • Age: Middle-aged adults are the only group with FMD data. Older users use the same starting grams and watch blood pressure and allergy more closely.

  • Baseline labs: Isolate is the form studied when HOMA-IR is above about 1.7 or triglycerides are high. Coat extract has no lab-gated dose.

  • Pre-existing disease: Uncontrolled diabetes, decompensated liver disease (liver failure with fluid buildup), and prior anaphylaxis were exclusion zones in trials and remain poor settings for unsupervised starts.

Discontinuation & Cycling

  • Duration: Extract is used as an ongoing food-like supplement, not a defined course. Nothing in the human file requires lifelong use.

  • Withdrawal: No withdrawal syndrome is described after isolate or coat extract. Stopping is abrupt in the published trials.

  • Taper: No receptor-level dependence is known. Tapering is unnecessary for the extract itself; concurrent blood-pressure or glucose drugs stay on their own schedules.

  • Cycling: No tolerance or cycling protocol is established. Benefits that exist were measured during continuous 6–8 week use.

  • Rechallenge after allergy: A convincing IgE reaction ends unsupervised reuse. Further exposure belongs in an allergy clinic, not a self-restart.

Sourcing and Quality

  • Name the fraction: Labels should state seed-coat extract (vitexin/isovitexin) or protein isolate (8S globulin), not a vague “mung bean extract” that could be either.

  • Standardization: Coat products that disclose vitexin and isovitexin content are closer to the Cao/Zhu chemistry than unassayed powders.

  • Third-party testing: Identity, heavy metals, and residual solvent certificates matter more here than brand story, because botanicals and protein isolates are both substitution-prone.

  • Named commercial forms: Life Extension Cytokine Suppress (coat extract plus EGCG; the company sells the product it writes about) and Fuji Oil GLUCODIA (isolate used in the Kohno trials) are the two reference products in the literature.

  • Protein-isolate regulation: Isolated mung bean protein has been treated as a novel food in European assessments; US products sit in the dietary-supplement or food-ingredient channel, not as approved drugs.

  • Whole-food substitute: Cooked beans and traditional soup are the historical form. They are not dose-equivalent to a 240 mg coat capsule or a 3 g isolate packet.

Practical Considerations

  • Time to effect: Insulin, triglyceride, and FMD changes were measured at 4–8 weeks. Coat-extract inflammation claims have no comparable human time course.

  • Common pitfalls: Buying isolate for a vitexin aim, or a flavone capsule for a 20 g protein aim; assuming soup equals a standardized extract; ignoring birch-pollen oral-allergy history.

  • Regulatory status: In the United States these are foods or dietary supplements, not drugs approved by the Food and Drug Administration. Marketing claims outrun the human file, as a warning letter over sprout-powder cholesterol claims illustrated.

  • Cost and access: Coat-extract capsules and 3 g isolate servings are inexpensive relative to prescription metabolic drugs. The binding constraint is product identity, not price.

Interaction with Foundational Habits

  • Sleep: No direct sedating or alerting effect is documented. Traditional use is a daytime cooling food, not a night-time hypnotic. Direction: none established.

  • Nutrition: Isolate is a methionine-limited plant protein and pairs with mixed meals; coat flavones ride along with polyphenol-rich diets. Whole beans add fiber and phytate. Direction: potentiating for protein-plus-meal metabolic aims; indirect mineral competition if phytate-rich meals dominate.

  • Exercise: Vegetarian strength data are from underactive adults, not trained lifters. Isolate does not replace a full protein target and has no evidence of blunting hypertrophy. Direction: modestly potentiating for inactive vegetarians; none shown for trained athletes.

  • Stress management: Coat-extract HMGB1 and NF-κB findings are biological-stress paths, not proof that extract substitutes for sleep or psychological stress work. Direction: indirect and mechanistic only.

Monitoring Protocol & Defining Success

Before starting, a baseline panel ties the chosen form to a measurable metabolic or inflammatory target and screens allergy risk. Isolated-protein users record fasting insulin, glucose (for HOMA-IR), triglycerides, and a liver enzyme. Coat-extract users add a high-sensitivity C-reactive protein if inflammation is the aim. Anyone with pollen or legume history documents prior reactions before the first serving. Repeat the same panel at 8 weeks, then every 6–12 months if use continues, with earlier checks at 2–4 weeks when ACE inhibitors or glucose drugs are already in combined use. Success is a move in the pre-chosen marker without new oral-allergy symptoms, not a change in how a person feels in the first few days.

Biomarker Optimal Functional Range Why Measure It? Context/Notes
Fasting insulin 2–6 μIU/mL Tracks isolate response Conventional labs often flag only values above ~20–25 μIU/mL; draw fasting, morning
HOMA-IR Below 1.5, ideally near 1.0 Primary isolate endpoint in trials Conventional insulin-resistance cutoffs often sit near 2.5; needs paired fasting glucose
Fasting glucose 70–85 mg/dL Safety when combined with glucose drugs Conventional upper limit is typically 99–100 mg/dL; main isolate trial did not lower this; still required to compute HOMA-IR
Triglycerides Below 90 mg/dL, ideally below 70 Isolate lipid endpoint Conventional upper limit is 150 mg/dL; 9–12 hour fast
ALT Below 25 U/L (men), below 20 U/L (women) Liver-fat companion marker ALT is alanine aminotransferase, a liver enzyme. Conventional upper limits are higher (~40 U/L); pair with AST (aspartate aminotransferase) if elevated
hs-CRP Below 0.7 mg/L Inflammatory baseline for coat extract hs-CRP is high-sensitivity C-reactive protein. Conventional “average risk” band is broader; avoid drawing during acute illness
Sitting / standing blood pressure Individual target, watch for a new drop ACE-peptide combination risk No trial proved a pressure drop; check if on lisinopril-class drugs

Qualitative markers

  • New oral itch, lip swelling, hives, or wheeze after a serving (stop and treat as allergy)
  • Bloating or cramping after whole-bean meals versus capsules
  • Unexplained lightheadedness if also on blood-pressure drugs
  • Energy and recovery only as secondary notes; they were not primary trial endpoints

Emerging Research

  • Completed isolate trial already published: NCT02322294 tested 8 weeks of GLUCODIA versus placebo on glucose, insulin, triglycerides, and body composition (n = 50) and is the Kohno 2018 dataset, not a pending surprise.

  • Completed vegetarian protein trial: NCT04076982 tested about 21 g/day supplementary protein, reported as 18 g/day mung bean protein, on lean mass and strength and corresponds to Bartholomae et al., 2019.

  • Mixed-legume diabetes food trial: NCT02999867 combined triticale, mung bean, and adzuki bean in type 2 diabetes (n = 180). A positive or null result would not isolate the extract from the food matrix.

  • No extract-specific trial is recruiting: ClinicalTrials.gov lists no ongoing coat-extract or isolate outcomes study. Open mung-bean records are whole-bean methionine-availability studies, not extract products.

  • AMPK-autophagy neuro models: Chen and colleagues (2026) reported that coat extract cleared disease proteins in worms and cells via AMPK-dependent autophagy (Chen et al., 2026). A human cognitive trial could raise or sink the neuro claim.

  • Industry-only metabolic file as a weakness: Both isolate efficacy papers share Fuji Oil authors. An independent HOMA-IR and triglyceride replication — or a clear null — would move the Medium-rated metabolic claims more than another manufacturer mouse study (Kohno et al., 2018).

  • Worm lifespan is not a human endpoint: Tao 2021 extended C. elegans life with coat flavonoids (Tao et al., 2021). A mammal lifespan or human epigenetic-clock study could support or retire that longevity extrapolation.

Conclusion

Mung bean extract is a family of products, not one molecule. Seed-coat preparations concentrate two plant flavones; protein isolates deliver the seed’s main storage protein and the fragments released when it is digested. Traditional use as a cooling summer food is old. The modern longevity interest rests on a thinner base: a few short human studies of the protein isolate, one drink trial in middle-aged adults, and a larger set of animal and cell findings on inflammation, heat stress, liver fat, and worm lifespan.

On the benefit side, isolated protein at a few grams a day has lowered insulin-resistance scores and triglycerides in manufacturer-funded trials, without a matching drop in fasting glucose. A protein drink improved vessel dilation and lowered some inflammatory signals. Coat flavones extend worm life and clear stress proteins in animals; those findings have not been measured as human lifespan outcomes. Life Extension, which sells a coat-extract capsule, and Fuji Oil, which makes the isolate used in the metabolic trials, each have a commercial stake in a favorable reading.

On the risk side, the bean is a documented food allergen with birch-pollen cross-reaction. Short trials reported good tolerance in people without that history. Gut symptoms and mineral binding belong more to the whole bean than to a low-fiber coat extract. For a risk-aware adult already managing insulin, blood fats, and inflammation, the extract is a low-cost add-on with a plausible mechanism and a still-narrow human evidence file.

Top - Benefits - Risks - Protocol